Royce & Associates LP Angiodynamics Inc Transaction History

Royce & Associates LP

$8.75 Billion
Q1 2025

A detailed history of Royce & Associates LP transactions in Angiodynamics Inc stock. As of the latest transaction made, Royce & Associates LP holds 1,027,630 shares of ANGO stock, worth $9.24 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

1,027,630

Previous 1,119,385 8.2%

Holding current value

$9.24 Million

Previous $10.3 Million 5.89%

% of portfolio

0.11%

Previous 0.1%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 06, 2025	SELL	$8.37 - $12.94 $767,989 - $1.19 Million	-91,755 Reduced 8.2%	1,027,630 $9.65 Million
Q4 2024 Feb 10, 2025	BUY	$5.88 - $9.33 $783,874 - $1.24 Million	133,312 Added 13.52%	1,119,385 $10.3 Million
Q3 2024 Nov 06, 2024	BUY	$5.51 - $7.84 $529,720 - $753,721	96,138 Added 10.8%	986,073 $7.67 Million
Q2 2024 Aug 13, 2024	BUY	$5.65 - $7.03 $2.12 Million - $2.64 Million	375,000 Added 72.82%	889,935 $5.38 Million
Q1 2024 May 13, 2024	BUY	$5.27 - $8.03 $2.71 Million - $4.13 Million	514,935 New	514,935 $3.02 Million
Q4 2020 Feb 08, 2021	SELL	$10.34 - $15.33 $1.85 Million - $2.75 Million	-179,225 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$8.26 - $12.74 $1.44 Million - $2.22 Million	-174,145 Reduced 49.28%	179,225 $2.16 Million
Q2 2020 Aug 07, 2020	SELL	$9.05 - $12.01 $349,999 - $464,474	-38,674 Reduced 9.86%	353,370 $3.59 Million
Q1 2020 May 12, 2020	SELL	$8.33 - $16.9 $915,092 - $1.86 Million	-109,855 Reduced 21.89%	392,044 $4.09 Million
Q4 2019 Feb 06, 2020	SELL	$14.23 - $18.16 $1.45 Million - $1.86 Million	-102,175 Reduced 16.91%	501,899 $8.04 Million
Q3 2019 Nov 13, 2019	SELL	$17.78 - $21.89 $782,231 - $963,050	-43,995 Reduced 6.79%	604,074 $11.1 Million
Q2 2019 Aug 12, 2019	SELL	$18.78 - $25.01 $290,639 - $387,054	-15,476 Reduced 2.33%	648,069 $12.8 Million
Q1 2019 May 09, 2019	SELL	$19.43 - $23.46 $1.79 Million - $2.16 Million	-92,199 Reduced 12.2%	663,545 $15.2 Million
Q4 2018 Feb 11, 2019	SELL	$18.9 - $22.06 $303,817 - $354,614	-16,075 Reduced 2.08%	755,744 $15.2 Million
Q3 2018 Nov 13, 2018	SELL	$18.95 - $24.23 $219,649 - $280,849	-11,591 Reduced 1.48%	771,819 $16.8 Million
Q2 2018 Aug 09, 2018	SELL	$17.42 - $23.0 $5.86 Million - $7.74 Million	-336,398 Reduced 30.04%	783,410 $17.4 Million
Q1 2018 May 14, 2018	BUY	$15.71 - $17.7 $329,768 - $371,540	20,991 Added 1.91%	1,119,808 $19.3 Million
Q4 2017 Feb 09, 2018	BUY	$16.56 - $17.8 $2.21 Million - $2.38 Million	133,660 Added 13.85%	1,098,817 $18.3 Million
Q3 2017 Nov 13, 2017	BUY	$16.09 - $18.76 $434,574 - $506,688	27,009 Added 2.88%	965,157 $16.5 Million
Q2 2017 Aug 07, 2017	BUY	N/A	938,148	938,148 $15.2 Million

Others Institutions Holding ANGO

# of Institutions

165

Shares Held

38.6M

Call Options Held

30.9K

Put Options Held

44.3K

View Full List

About ANGIODYNAMICS INC

Ticker ANGO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 39,107,800
Market Cap $352M
Description
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation syst...

More about ANGO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Account

Royce & Associates LP Angiodynamics Inc Transaction History